Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 545 entries
View as:

Significance of Fluorescence Colposcopy With Autofluorescence Imaging for Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01854983 Org: User:
Start: 05/31/13 End: 04/30/14 Due: 04/30/15

Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular Disease

Phase: N/A Priority: Normal
NCT ID: NCT02982850 Org: User:
Start: 12/31/16 End: 10/31/20 Due: 10/31/21

FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01170923 Org: User:
Start: 09/30/08 End: - Due: -

Effect of Remote Ischemic Preconditioning on Cognitive Function After Off-Pump Coronary Artery Bypass Graft

Phase: N/A Priority: Normal
NCT ID: NCT00953368 Org: User:
Start: 10/31/09 End: 03/31/12 Due: 03/31/13

Effect of Preoperative Exercise on the Prevention of Secondary Lymphedema in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06421285 Org: User:
Start: 01/10/25 End: 12/31/25 Due: 12/31/26

Abbreviated 3 Cycles of Rituximab Plus CHOP(Cyclophosphamide, Adriamycin, Vincristine, and Prednisolone) Immunochemotherapy in Patients With Completely Excised LocalizedGastrointestinal CD(Cluster of Differentiation Antigen)20(+) Diffuse Large B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03399747 Org: User:
Start: 12/07/16 End: 12/31/24 Due: 12/31/25

Visual Perceptual Learning for the Treatment of Visual Field Defect

Phase: N/A Priority: Normal
NCT ID: NCT01959256 Org: User:
Start: 10/31/13 End: 01/31/18 Due: 01/31/19

Prediction Model for Response to Biologics and Small Molecular Agent for UC

Phase: N/A Priority: Normal
NCT ID: NCT05186623 Org: User:
Start: 02/05/22 End: 12/31/26 Due: 12/31/27

Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02268435 Org: User:
Start: 03/31/15 End: 11/30/16 Due: 11/30/17

Chronic Myelod Leukemia Registry at Asan Medical Center

Phase: N/A Priority: Normal
NCT ID: NCT01761695 Org: User:
Start: 01/31/13 End: 05/31/16 Due: 05/31/17

Plasma Citrulline: A Marker for Monitoring & Quantifying Radiation-Induced Small Bowel Toxicity

Phase: N/A Priority: Normal
NCT ID: NCT01849107 Org: User:
Start: 04/30/13 End: 12/31/14 Due: 12/31/15

ABO-Incompatible Kidney Transplants Between Robot-Assisted vs. Open Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06287008 Org: User:
Start: 10/01/20 End: 01/31/24 Due: 01/31/25

Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XP

Phase: N/A Priority: Normal
NCT ID: NCT00565370 Org: User:
Start: 11/30/07 End: 12/31/09 Due: 12/31/10

Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT03920033 Org: User:
Start: 05/01/19 End: 01/01/27 Due: 01/01/28

EFficacy of Prophylactic Clip Application in Decrease of Immediate Postpolypectomy Bleeding and Delayed Postpolypectomy Bleeding After Colonoscopic Removal for a Large Pedunculated Polyps

Phase: N/A Priority: Normal
NCT ID: NCT01437631 Org: User:
Start: 09/01/11 End: 04/30/15 Due: 04/30/16

Tezepelumab Treatment in Korean Severe Asthma Patients

Phase: N/A Priority: Normal
NCT ID: NCT06438913 Org: User:
Start: 06/12/24 End: 12/31/26 Due: 12/31/27

Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE

Phase: N/A Priority: Normal
NCT ID: NCT01187212 Org: User:
Start: 08/31/10 End: 08/31/14 Due: 08/31/15

Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin

Phase: N/A Priority: Normal
NCT ID: NCT01437670 Org: User:
Start: 09/30/11 End: 12/31/13 Due: 12/31/14

The Effect of Leg Position on the Sciatic Nerve on Sonogram

Phase: N/A Priority: Normal
NCT ID: NCT03678961 Org: User:
Start: 08/30/18 End: 10/11/18 Due: 10/11/19

Patient Transfer Monitoring System in Hospital Using Mobile IoT Technology

Phase: N/A Priority: Normal
NCT ID: NCT03574272 Org: User:
Start: 05/16/18 End: 12/28/18 Due: 12/28/19

Multicenter, Prospective Study for Urinary Exosomal Biomarkers of Kidney Allograft Tubulointerstitial Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT03870542 Org: User:
Start: 05/11/19 End: 04/30/22 Due: 04/30/23

Trial of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, S-1 Followed by Surgery and Adjuvant Durvalumab Plus S-1 Chemotherapy in Potentially Resectable MMR Proficient Gastric or Gastroesophageal Junction Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04221555 Org: User:
Start: 05/13/20 End: 04/30/25 Due: 04/30/26

The Epidemiology of TST Change in Korea

Phase: N/A Priority: Normal
NCT ID: NCT01850043 Org: User:
Start: 05/31/05 End: 05/31/12 Due: 05/31/13

Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the Brain

Phase: N/A Priority: Normal
NCT ID: NCT03510572 Org: User:
Start: 06/04/18 End: 07/31/19 Due: 07/31/20

Steroid, Thiamine and Ascorbic Acid for Comatose Out-of-hospital Cardiac Arrest Survivors

Phase: N/A Priority: Normal
NCT ID: NCT04921189 Org: User:
Start: 12/31/21 End: 06/09/25 Due: 06/09/26